What is Sharps Technology?
Sharps Technology operates as a specialized medical device manufacturer headquartered in Melville, New York. The company is primarily focused on the development and commercialization of smart safety syringes, a critical innovation designed to address the persistent global health challenge of accidental needlestick injuries, which account for millions of potentially infectious incidents annually. By integrating advanced engineering with clinical safety requirements, Sharps Technology occupies a vital niche in the healthcare supply chain, providing essential tools that protect frontline medical professionals and improve patient outcomes. Their market position is defined by a commitment to reducing healthcare-associated costs and enhancing safety protocols through technological intervention.
How much funding has Sharps Technology raised?
Sharps Technology has raised a total of $814.4M across 3 funding rounds:
Share Placement
$3.5M
Stock/Share Issuance
$400M
Stock/Share Issuance
$410.9M
Share Placement (2024): $3.5M with participation from Aegis Capital Corp
Stock/Share Issuance (2025): $400M, investors not publicly disclosed
Stock/Share Issuance (2025): $410.9M, investors not publicly disclosed
Key Investors in Sharps Technology
Aegis Capital Corp
Aegis Capital Corporation is a full-service investment banking firm with over 35 years of experience, providing institutional and corporate clients with a comprehensive suite of financial services including equity research and private equity.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Sharps Technology?
With the recent infusion of capital, Sharps Technology is expected to prioritize the expansion of its production capacity and the intensification of its commercial distribution networks. The strategic focus will likely shift toward securing broader regulatory approvals and establishing long-term supply agreements with major healthcare systems and hospital networks. As the firm scales, the integration of its smart syringe technology into standard clinical practice will be the primary driver of long-term value creation. Investors and industry stakeholders will be monitoring the company's ability to convert this financial momentum into sustained market share gains and improved safety metrics across the medical device landscape.
See full Sharps Technology company page
